BR100 Increased By (0.91%)
BR30 Increased By (1.13%)
KSE100 Increased By (0.9%)
KSE30 Increased By (1%)
AGHA 6.49 Increased By ▲ 0.11 (1.72%)
BECO 4.39 Increased By ▲ 0.04 (0.92%)
BML 62.30 Decreased By ▼ -0.25 (-0.4%)
BOP 31.49 Increased By ▲ 0.10 (0.32%)
CNERGY 11.86 Increased By ▲ 0.13 (1.11%)
CSIL 5.86 Decreased By ▼ -0.05 (-0.85%)
FCCL 62.35 Increased By ▲ 0.64 (1.04%)
FFL 14.95 Increased By ▲ 0.16 (1.08%)
FNEL 1.31 Increased By ▲ 0.07 (5.65%)
KEL 6.35 Increased By ▲ 0.03 (0.47%)
KOSM 5.86 Decreased By ▼ -0.04 (-0.68%)
LOTCHEM 24.72 Increased By ▲ 0.03 (0.12%)
MLCF 106.40 Increased By ▲ 2.47 (2.38%)
NBP 174.41 Increased By ▲ 1.09 (0.63%)
NCPL 52.21 Increased By ▲ 0.38 (0.73%)
NPL 55.00 Increased By ▲ 0.97 (1.8%)
OGDC 319.75 Increased By ▲ 3.88 (1.23%)
PACE 9.33 Increased By ▲ 0.07 (0.76%)
PAEL 35.93 Increased By ▲ 0.35 (0.98%)
PIBTL 13.90 Increased By ▲ 0.24 (1.76%)
PPL 228.61 Increased By ▲ 2.54 (1.12%)
PRL 81.70 Increased By ▲ 1.42 (1.77%)
PTC 47.15 Increased By ▲ 0.51 (1.09%)
SSGC 24.05 Increased By ▲ 0.23 (0.97%)
TBL 9.25 Increased By ▲ 0.01 (0.11%)
TELE 7.54 Decreased By ▼ -0.01 (-0.13%)
TPL 25.00 Increased By ▲ 0.46 (1.87%)
TPLP 13.15 Increased By ▲ 0.16 (1.23%)
TREET 26.03 Increased By ▲ 0.05 (0.19%)
TRG 53.80 Increased By ▲ 0.47 (0.88%)
World

Italy's medicines authority bans a batch of Astrazeneca's vaccine

  • Aifa said that the move was "precautionary" as no link between the inoculation of the vaccine and these events had been established to date.
  • The agency is carrying out all required checks and the batch will be analysed by Italy's Superior Health Institute ISS, it added.
Published Updated
By

ROME: Italy's medicines authority Aifa said on Thursday it would ban the use of doses of the AstraZeneca vaccine belonging to the ABV2856 batch after notifications of some serious adverse effects.

Aifa said that the move was "precautionary" as no link between the inoculation of the vaccine and these events had been established to date.

The agency is carrying out all required checks and the batch will be analysed by Italy's Superior Health Institute ISS, it added.

Comments

Comments are closed for this article.